Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
  • Events
  • Job Board
In Brief

Emory Healthcare, AccessHope collaborate to extend access to cancer expertise

Emory Healthcare, Winship Cancer Institute of Emory University, and AccessHope LLC entered a collaboration that aims to expand access to specialized cancer expertise to people living with complex cancers across the United States. 
January 14, 2022
Vol.48 No.02

Posts navigation

Previous12

Trending Stories

  • NIH eliminates the NCI Board of Scientific Advisors
    Over its 28 year history, BSA shaped NCI-funded extramural science
  • Trump administration is removing the mainstays of NCI and the federal government’s cancer program
    Peer review, registries, and evidence-based patient information take a big hit
  • Bhattacharya cancels NIH all-hands meeting
  • Cyber-iconoclast Vinay Prasad named head of FDA’s CBER
    An oncologist, Prasad has criticized accelerated approval, next-gen sequencing, and targeted therapies
  • In the Headlines: “There’s no one to stand up for NCI right now.”
  • George Weiner: Cancer centers are special, as are site visits in CCSG review

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2025 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Request Cancellation

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account